Chenhe Zhao
Overview
Explore the profile of Chenhe Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Y, Liu G, Zhang Y, Xu G, Yi X, Liang J, et al.
Front Endocrinol (Lausanne)
. 2020 Sep;
11:497.
PMID: 32903642
Serum phosphate plays an important role in bone mineralization and might be a risk factor for many bone diseases. Patients with T2D usually have low serum phosphate level due to...
2.
Yang Y, Zhao C, Ye Y, Yu M, Qu X
Front Endocrinol (Lausanne)
. 2020 May;
11:190.
PMID: 32351447
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new family of antidiabetic drugs that reduce blood glucose independent of insulin. In this review, we present the advantages and adverse effects of...
3.
Liang J, Yi X, Xue M, Chen X, Huang X, Sun Q, et al.
J Clin Lab Anal
. 2020 Jan;
34(5):e23192.
PMID: 31981248
Background: The correlation between preoperative lipid profiles and new-onset diabetes after transplantation (NODAT) remains relatively unexplored in liver transplant recipients (LTRs). Thus, we aimed to investigate the preoperative lipid profiles...
4.
Zhao C, Liu G, Zhang Y, Xu G, Yi X, Liang J, et al.
J Clin Lab Anal
. 2019 Nov;
34(4):e23112.
PMID: 31733013
Background: In patients with type 2 diabetes mellitus (T2DM), higher risks of impaired bone metabolism are widely reported. To evaluate bone metabolism, bone mineral density (BMD) and bone turnover levels...
5.
Ye Y, Zhao C, Liang J, Yang Y, Yu M, Qu X
Front Pharmacol
. 2019 Jan;
9:1517.
PMID: 30670968
The effect of anti-diabetic medications on bone metabolism has received increasing attention, considering that type 2 diabetes mellitus is a common metabolic disorder with adverse effects on bone metabolism. Sodium-glucose...
6.
Yang Y, Liu G, Zhang Y, Xu G, Yi X, Liang J, et al.
Front Endocrinol (Lausanne)
. 2018 Nov;
9:646.
PMID: 30459714
The association between bone mineral density (BMD), bone turnover markers, and serum cholesterol in healthy population has already been proved. However, in patients with type 2 diabetes mellitus (T2D), it...
7.
Liang J, Lv C, Chen M, Xu M, Zhao C, Yang Y, et al.
J Diabetes
. 2018 Sep;
11(5):370-378.
PMID: 30203544
Background: The effects of preoperative hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, and HBV plus HCV coinfection on the development of new-onset diabetes after transplantation (NODAT) remain...
8.
Xue M, Zhao C, Lv C, Chen M, Xu M, Rong R, et al.
J Diabetes
. 2018 Mar;
10(11):857-865.
PMID: 29577632
Background: The aim of the present study was to examine the association between interleukin-2 receptor antagonists (IL-2Ra) and new-onset diabetes after transplantation (NODAT) among renal transplant recipients (RTRs). Methods: Between...
9.
Yang Y, Zhao C, Liang J, Yu M, Qu X
Front Pharmacol
. 2017 Aug;
8:487.
PMID: 28790917
Diabetes mellitus has been demonstrated to be closely associated with osteoporosis. Accordingly, hypoglycemic therapy is considered effective in treating metabolic bone disease. Recently, the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors,...
10.
Zhao C, Liang J, Yang Y, Yu M, Qu X
Front Endocrinol (Lausanne)
. 2017 May;
8:98.
PMID: 28515711
The impact of antidiabetic drugs on bone metabolism is drawing increasing attention due to the discovery of a correlation between type 2 diabetes mellitus (T2DM) and osteoporosis. Glucagon-like peptide-1 (GLP-1)...